Updated: May 28, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Aoqi Wang1, Jiajia Liu2, Jianguo Wen2
1West China Biomedical Big Data Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This article introduces a conceptual framework for a multi-layered artificial intelligence system designed to connect biological data across all scales, from individual molecules to the entire human body, to improve disease understanding and personalized treatment strategies.
Area of Science:
Background:
Current computational tools often struggle to bridge the gap between distinct biological hierarchies. Most existing models focus on isolated tasks rather than holistic physiological integration. Researchers lack a unified architecture to synthesize molecular, cellular, and systemic data simultaneously. This fragmentation prevents a comprehensive understanding of how microscopic changes influence whole-body health outcomes. No prior work had resolved the challenge of connecting disparate data types into a single coherent reasoning engine. That uncertainty drove the need for a new conceptual blueprint in the field. This perspective addresses the limitations of narrow, task-specific approaches in modern biomedical research. The proposed framework aims to standardize how we interpret complex biological interactions across multiple levels.
Purpose Of The Study:
The authors aim to introduce a conceptual blueprint for a multi-agent system in systemic biology. This work addresses the difficulty of connecting molecular alterations to whole-body phenotypes in current research. The researchers seek to provide a framework that standardizes biomedical data across seven distinct biological levels. They intend to clarify the basis for future cross-scale artificial intelligence systems. This study motivates the transition from task-specific models to holistic physiological reasoning. The team addresses the need for transparent and physiology-constrained computational tools. They provide a foundation for improving disease analysis and therapeutic evaluation. This perspective serves as a guide for future developments in personalized medicine.
The researchers propose a hierarchical multi-agent framework where a supervisory agent coordinates seven specialized entities. These agents, ranging from molecular to body-system levels, standardize data and integrate outputs through iterative feedback loops to enable cross-scale reasoning.
The framework utilizes a data commons and harmonization mechanisms to manage information. These components ensure that diverse inputs from different biological scales are standardized and traceable, allowing the system to maintain consistency while processing complex, multi-level evidence.
Arbitration strategies and uncertainty handling are necessary to resolve conflicts between agents. These technical requirements allow the system to manage discrepancies in multi-level evidence, ensuring that the final output remains grounded in biological reality rather than just statistical correlation.
Main Methods:
The review approach involves constructing a hypothetical multi-agent architecture for systemic biology. Researchers evaluated existing limitations in current computational models to define the necessary framework requirements. They established a seven-level hierarchy to categorize biological data from molecular to systemic scales. The team outlined specific protocols for data harmonization and cross-scale reasoning. They developed arbitration strategies to manage potential conflicts between different agent levels. The authors utilized conceptual modeling to demonstrate how the framework handles complex biological inquiries. They applied this design to two distinct scenarios to test the logic of the proposed system. This methodology focuses on establishing a theoretical foundation for future software implementation.
Main Results:
The strongest finding involves the creation of a seven-level agent hierarchy for systemic biological reasoning. This framework successfully organizes evidence from molecular changes to whole-body phenotypes. The authors demonstrate that this structure facilitates the integration of diverse data types. They show how iterative feedback loops improve the coherence of cross-scale biological analysis. The model provides a clear pathway for standardizing biomedical data across different scales. The researchers identify specific requirements for traceability and uncertainty management in automated systems. These findings suggest that physiology-constrained logic enhances the accuracy of therapeutic evaluation. The study establishes a conceptual basis for future development in personalized medicine.
Conclusions:
The authors propose a multi-agent structure to facilitate cross-scale biological reasoning. This framework organizes seven distinct levels of analysis to ensure comprehensive data integration. The researchers suggest that this approach could improve the accuracy of disease modeling. They emphasize the necessity of traceability safeguards to maintain transparency in automated decision-making. The synthesis implies that future systems should prioritize physiology-constrained logic over purely data-driven patterns. This model provides a foundation for more effective therapeutic evaluation in clinical settings. The authors argue that iterative feedback loops are vital for refining systemic predictions. This perspective serves as a guide for developing future artificial intelligence architectures in precision medicine.
The framework employs a supervisory agent to assign level-specific tasks and integrate outputs. This role is vital for decomposing complex cross-scale questions, ensuring that each agent contributes relevant information to the final systemic analysis.
The authors demonstrate the framework using metastasis analysis and drug development. These scenarios illustrate how the system organizes evidence from molecular alterations to systemic phenotypes, showing potential for improved therapeutic evaluation and personalized medicine.
The researchers propose that this blueprint will provide a foundation for transparent, physiology-constrained systems. They suggest this approach will improve disease analysis and personalized medicine by connecting molecular changes to whole-body outcomes.